期刊
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
卷 34, 期 1, 页码 37-49出版社
SPRINGER
DOI: 10.1007/s00270-010-0012-y
关键词
Interventional radiology; Liver cancer; Chemoembolization
资金
- GENENTECH, INC.
- BIOSPHERE MEDICAL
- CONTEXTVISION, INC.
- BOSTON SCIENTIFIC
Conventional transcatheter arterial chemoembolization and chemoembolization with drug-eluting beads are increasingly being performed interchangeably in many institutions throughout the world. As both therapies continue to being tested in many phase II and III studies and in combination with other therapies, especially targeted agents, for treatment of primary and metastatic liver cancer, it is imperative to review their current status and evaluate their impact on patient survival. This review critically assesses patient selection, indications, contraindications, techniques, materials, safety, and clinical outcomes of patients treated with conventional chemoembolization and chemoembolization with drug-eluting beads.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据